1. Home
  2. FULC vs CCRD Comparison

FULC vs CCRD Comparison

Compare FULC & CCRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • CCRD
  • Stock Information
  • Founded
  • FULC 2015
  • CCRD 1973
  • Country
  • FULC United States
  • CCRD United States
  • Employees
  • FULC N/A
  • CCRD N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • CCRD
  • Sector
  • FULC Health Care
  • CCRD
  • Exchange
  • FULC Nasdaq
  • CCRD Nasdaq
  • Market Cap
  • FULC 210.9M
  • CCRD 192.4M
  • IPO Year
  • FULC 2019
  • CCRD N/A
  • Fundamental
  • Price
  • FULC $3.85
  • CCRD $21.37
  • Analyst Decision
  • FULC Hold
  • CCRD Hold
  • Analyst Count
  • FULC 9
  • CCRD 1
  • Target Price
  • FULC $7.63
  • CCRD $15.00
  • AVG Volume (30 Days)
  • FULC 368.1K
  • CCRD 21.2K
  • Earning Date
  • FULC 02-25-2025
  • CCRD 02-20-2025
  • Dividend Yield
  • FULC N/A
  • CCRD N/A
  • EPS Growth
  • FULC N/A
  • CCRD 67.50
  • EPS
  • FULC N/A
  • CCRD 0.67
  • Revenue
  • FULC $80,871,000.00
  • CCRD $57,399,000.00
  • Revenue This Year
  • FULC $2,823.78
  • CCRD $1.95
  • Revenue Next Year
  • FULC N/A
  • CCRD $12.19
  • P/E Ratio
  • FULC N/A
  • CCRD $32.12
  • Revenue Growth
  • FULC 2987.86
  • CCRD 2.49
  • 52 Week Low
  • FULC $2.86
  • CCRD $10.02
  • 52 Week High
  • FULC $13.70
  • CCRD $24.97
  • Technical
  • Relative Strength Index (RSI)
  • FULC 47.75
  • CCRD 41.37
  • Support Level
  • FULC $3.64
  • CCRD $21.50
  • Resistance Level
  • FULC $3.94
  • CCRD $23.50
  • Average True Range (ATR)
  • FULC 0.18
  • CCRD 1.25
  • MACD
  • FULC 0.02
  • CCRD -0.20
  • Stochastic Oscillator
  • FULC 84.21
  • CCRD 0.58

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About CCRD CoreCard Corporation

CoreCard Corp is engaged in the business of providing technology solutions and processing services to the financial technology and services market. It designs, develops and markets a comprehensive suite of software solutions to program managers, accounts receivable businesses, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, buy now pay later programs, loyalty programs and accounts receivable and loan transactions. The CoreCard software platform and modules include CoreENGINE, CoreISSUE, CoreFRAUD, CoreCOLLECT, CoreAPP, CoreMONEY and CoreACQUIRE. Its customers are located in the U.S, European Union and the Middle East of which key revenue is derived from the U.S.

Share on Social Networks: